ProfileGDS5678 / 1449365_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 55% 52% 52% 53% 51% 53% 52% 51% 52% 51% 52% 53% 52% 52% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.4382555
GSM967853U87-EV human glioblastoma xenograft - Control 23.2672152
GSM967854U87-EV human glioblastoma xenograft - Control 33.2550852
GSM967855U87-EV human glioblastoma xenograft - Control 43.2326153
GSM967856U87-EV human glioblastoma xenograft - Control 53.1719351
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.3925453
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.3610252
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.2327351
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.2493352
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.2212451
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.261652
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.2522853
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.2763652
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.2531452